Hess, Jonathan L.
Nguyen, Nicholas H.
Suben, Jesse
Meath, Ryan M.
Albert, Avery B.
Van Orman, Sarah
Anders, Kristin M.
Forken, Patricia J. http://orcid.org/0000-0002-9931-9753
Roe, Cheryl A.
Schulze, Thomas G.
Faraone, Stephen V.
Glatt, Stephen J.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (RO1MH101519, RO1MH101519, RO1MH101519, RO1MH101519, RO1MH101519, RO1MH101519, RO1MH101519, RO1MH101519, RO1MH101519, RO1MH101519)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 30 December 2019
Revised: 29 May 2020
Accepted: 3 September 2020
First Online: 23 September 2020
Conflict of Interest
: J.L.H., N.H.N., J.S., R.M.M., A.B.A., S.V., K.A., P.F., C.A.R., and T.G.S. have no conflicts of interest to disclose. In the past year, Dr. Faraone received income, potential income, travel expenses continuing education support and/or research support from Tris, Otsuka, Arbor, Ironshore, Shire, Akili, Enzymotec, Sunovion, Supernus and Genomind. With his institution, he has US patent US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. In previous years, he received support from: Shire, Ironshore, Neurovance, Alcobra, Rhodes, CogCubed, KemPharm, Enzymotec, Akili, Neurolifesciences, Lundbeck/Takeda, Otsuka, McNeil, Janssen, Novartis, Pfizer, and Eli Lilly. He also receives royalties from books published by Guilford Press: Straight Talk about Your Child’s Mental Health, Oxford University Press: Schizophrenia: The Facts and Elsevier: ADHD: Non-Pharmacologic Interventions. He is principal investigator of ExternalRef removed. In the past year, S.J.G. received royalties from a book published by Oxford University Press: Schizophrenia: The Facts.